The organization known as Veterans Prostate Cancer Awareness (VPCa) was initially founded by Mike (“Bing”) Crosby back in 2016. … READ MORE …
Filed under: Uncategorized | Tagged: awareness, veteran, VPCa | Leave a comment »
The organization known as Veterans Prostate Cancer Awareness (VPCa) was initially founded by Mike (“Bing”) Crosby back in 2016. … READ MORE …
Filed under: Uncategorized | Tagged: awareness, veteran, VPCa | Leave a comment »
A newly published article in the journal Frontiers in Oncology suggests that men diagnosed with prostate cancer at ≥ 70 years of age may be more likely to die of their prostate cancer than younger men, regardless of their PSA level at diagnosis. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: incidence, mortality, risk, VA, veteran | 3 Comments »
A new article on the Medscape Oncology web site provides a summary update of information related to risk for prostate cancer and other urologic cancers specific to U.S. veterans who served in Vietnam. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Agent Orange, exposure, veteran | 1 Comment »
A study reported this week in the Archives of Internal Medicine addresses the impact of biochemical recurrence on risk for prostate cancer-specific mortality (PCSM) among a cohort of more than 1,000 US veterans initially diagnosed and treated between 1991 and 1995. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: biochemical recurrence, long-term, outcome, radical prostatectomy, radiotherapy, veteran | 7 Comments »
The current report offers a revised and updated commentary on the paper by Abd et al., first referred to yesterday on this blog. We have now had the opportunity to read the entire paper. While it does not change the general tenor of our prior comments, it is useful to make sure one has all relevant information on a topic this important. … READ MORE …
Filed under: Diagnosis | Tagged: biopsy, cores, Diagnosis, number, positive, veteran | Leave a comment »